22840-0215 NDC - TIMOTHY-ORCHARD STANDARDIZED GRASS POLLEN MIX (PHLEUM PRATENSE AND DACTYLIS GLOMERATA)

Drug Information

Product NDC: 22840-0215

Proprietary Name: Timothy-Orchard Standardized Grass Pollen Mix

Non Proprietary Name: Phleum pratense and Dactylis glomerata

Active Ingredient(s):
  • 50000 [BAU]/mL DACTYLIS GLOMERATA POLLEN;
  • 50000 [BAU]/mL PHLEUM PRATENSE POLLEN


Administration Route(s): INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS

Dosage Form(s): SOLUTION

Pharmacy Class(es):
  • Standardized Pollen Allergenic Extract [EPC];
  • Increased Histamine Release [PE];
  • Cell-mediated Immunity [PE];
  • Increased IgG Production [PE];
  • Pollen [CS];
  • Allergens [CS];
  • Standardized Pollen Allergenic Extract [EPC];
  • Increased Histamine Release [PE];
  • Cell-mediated Immunity [PE];
  • Increased IgG Production [PE];
  • Pollen [CS];
  • Allergens [CS]

Labeler Information

Labeler Name: Greer Laboratories, Inc.
Product Type: STANDARDIZED ALLERGENIC
FDA Application Number: BLA101843
Marketing Category: BLA
Start Marketing Date:9/15/1968

Package Information

No. Package Code Package Description Billing Unit
122840-0215-210 mL in 1 VIAL, MULTI-DOSE (22840-0215-2)
222840-0215-450 mL in 1 VIAL, MULTI-DOSE (22840-0215-4)
322840-0215-55 mL in 1 BOTTLE, DROPPER (22840-0215-5)

NDC Record

Field Name Field Value Definition
PRODUCT NDC22840-0215The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMESTANDARDIZED ALLERGENICIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMETimothy-Orchard Standardized Grass Pollen MixThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEPhleum pratense and Dactylis glomerataThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESOLUTIONThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEINTRADERMAL; PERCUTANEOUS; SUBCUTANEOUSThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE9/15/1968This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEBLAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERBLA101843This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEGreer Laboratories, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEDACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLENThis is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH50000; 50000 
ACTIVE INGRED UNIT[BAU]/mL; [BAU]/mL 
PHARM CLASSESStandardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 8/16/2019